InsiderClue
Stocks · Health care · Pharmaceutical Preparations

AYTU BIOPHARMA, INC

AYTU Clue Score35
United States Fiscal year ends June CIK 0001385818
$2.03 -1.22% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.03 −23.58% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 1 Feb 2017. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue3.2Operating income−20.1Net income−22.5Fiscal year 2018Revenue3.7 +13.6%Operating income−19.7Net income−10.2Fiscal year 2019Revenue7.3 +100.0%Operating income−16.8Net income−27.1Fiscal year 2020Revenue27.6 +277.5%Operating income−21.1Net income−13.6Fiscal year 2021Revenue65.6 +137.5%Operating income−58.9Net income−58.3EPS, diluted−3.48Fiscal year 2022Revenue96.7 +47.3%Operating income−109.9Net income−108.8EPS, diluted−74.01Fiscal year 2023Revenue107.4 +11.1%Operating income−17.1Net income−17.1EPS, diluted−5.11Fiscal year 2024Revenue65.2 −39.3%Operating income−1.6Net income−15.8Fiscal year 2025Revenue66.4 +1.8%Operating income−7.8Net income−13.6Fiscal year 2026Revenue57.6 −13.3%Operating income−8.3Net income−14.3
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue 3.2 3.7 7.3 27.6 65.6 96.7 107.4 65.2 66.4 57.6
Growth +13.6% +100.0% +277.5% +137.5% +47.3% +11.1% −39.3% +1.8% −13.3%
Operating income −20.1 −19.7 −16.8 −21.1 −58.9 −109.9 −17.1 −1.6 −7.8 −8.3
Net income −22.5 −10.2 −27.1 −13.6 −58.3 −108.8 −17.1 −15.8 −13.6 −14.3
Growth
EPS, diluted n/a n/a n/a n/a −3.48 −74.01 −5.11 n/a n/a n/a

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2017Operating margin−624.7%Net margin−698.7%Free cash flow margin−432.7%Fiscal year 2018Operating margin−538.2%Net margin−278.3%Free cash flow margin−437.6%Fiscal year 2019Operating margin−230.1%Net margin−370.6%Free cash flow margin−189.8%Fiscal year 2020Gross margin70.0%Operating margin−76.5%Net margin−49.3%Free cash flow margin−102.7%Fiscal year 2021Gross margin44.5%Operating margin−89.7%Net margin−88.8%Free cash flow margin−43.1%Fiscal year 2022Gross margin54.1%Operating margin−113.7%Net margin−112.5%Free cash flow margin−29.8%Fiscal year 2023Gross margin62.0%Operating margin−15.9%Net margin−15.9%Fiscal year 2024Gross margin75.3%Operating margin−2.4%Net margin−24.3%Free cash flow margin−2.6%Fiscal year 2025Gross margin69.0%Operating margin−11.8%Net margin−20.4%Free cash flow margin−3.3%Fiscal year 2026Gross margin64.0%Operating margin−14.4%Net margin−24.8%Free cash flow margin5.6%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Gross margin n/a n/a n/a 70.0% 44.5% 54.1% 62.0% 75.3% 69.0% 64.0%
Operating margin −624.7% −538.2% −230.1% −76.5% −89.7% −113.7% −15.9% −2.4% −11.8% −14.4%
Net margin −698.7% −278.3% −370.6% −49.3% −88.8% −112.5% −15.9% −24.3% −20.4% −24.8%
Free cash flow margin −432.7% −437.6% −189.8% −102.7% −43.1% −29.8% n/a −2.6% −3.3% 5.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−13.8Capital expenditure−0.1Free cash flow−13.9Fiscal year 2018Operating cash flow−15.9Capital expenditure−0.1Free cash flow−16.0Fiscal year 2019Operating cash flow−13.8Capital expenditure−0.1Free cash flow−13.9Fiscal year 2020Operating cash flow−28.4Capital expenditure0.0Free cash flow−28.4Fiscal year 2021Operating cash flow−26.0Capital expenditure−2.3Free cash flow−28.3Fiscal year 2022Operating cash flow−28.8Capital expenditure0.0Free cash flow−28.8Fiscal year 2023Operating cash flow−5.1Fiscal year 2024Operating cash flow−1.4Capital expenditure−0.3Free cash flow−1.7Fiscal year 2025Operating cash flow−1.9Capital expenditure−0.2Free cash flow−2.2Fiscal year 2026Operating cash flow3.3Capital expenditure−0.0Free cash flow3.3
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow −13.8 −15.9 −13.8 −28.4 −26.0 −28.8 −5.1 −1.4 −1.9 3.3
Capital expenditure −0.1 −0.1 −0.1 0.0 −2.3 0.0 n/a −0.3 −0.2 −0.0
Free cash flow −13.9 −16.0 −13.9 −28.4 −28.3 −28.8 n/a −1.7 −2.2 3.3
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash0.8Shareholders’ equity4.0Fiscal year 2018Cash7.0Total debt0.0Net cash (debt)7.0Shareholders’ equity13.4Debt to equity0.00Fiscal year 2019Cash11.0Total debt0.0Net cash (debt)11.0Shareholders’ equity7.1Debt to equity0.00Fiscal year 2020Cash48.1Shareholders’ equity95.0Fiscal year 2021Cash49.6Shareholders’ equity137.6Fiscal year 2022Cash19.4Total debt15.0Net cash (debt)4.4Shareholders’ equity44.3Debt to equity0.34Fiscal year 2023Cash23.0Total debt14.8Net cash (debt)8.2Shareholders’ equity39.4Debt to equity0.38Fiscal year 2024Cash20.0Total debt12.7Net cash (debt)7.3Shareholders’ equity27.7Debt to equity0.46Fiscal year 2025Cash31.0Total debt12.8Net cash (debt)18.2Shareholders’ equity19.0Debt to equity0.67Fiscal year 2026Cash26.3Total debt11.0Net cash (debt)15.4Shareholders’ equity35.3Debt to equity0.31
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash 0.8 7.0 11.0 48.1 49.6 19.4 23.0 20.0 31.0 26.3
Total debt n/a 0.0 0.0 n/a n/a 15.0 14.8 12.7 12.8 11.0
Net cash (debt) n/a 7.0 11.0 n/a n/a 4.4 8.2 7.3 18.2 15.4
Shareholders’ equity 4.0 13.4 7.1 95.0 137.6 44.3 39.4 27.7 19.0 35.3
Debt to equity n/a 0.00 0.00 n/a n/a 0.34 0.38 0.46 0.67 0.31

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2026 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending June, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 30 Jun 2017 FY2018 30 Jun 2018 FY2019 30 Jun 2019 FY2020 30 Jun 2020 FY2021 30 Jun 2021 FY2022† 30 Jun 2022 FY2023† 30 Jun 2023 FY2024 30 Jun 2024 FY2025 30 Jun 2025 FY2026 30 Jun 2026
Revenue and profit
3.2 3.7 7.3 27.6 65.6 96.7 107.4 65.2 66.4 57.6
Growth +13.6% +100.0% +277.5% +137.5% +47.3% +11.1% −39.3% +1.8% −13.3%
1.4 2.1 2.2 8.3 36.4 44.4 40.8 16.1 20.6 20.8
n/a n/a n/a 19.4 29.2 52.3 66.6 49.1 45.8 36.8
Growth +50.9% +79.1% +27.4% −26.4% −6.6% −19.7%
1.0 0.2 0.6 1.7 5.6 12.7 4.1 2.8 1.3 0.0
17.4 17.7 18.9 34.8 25.5 31.2 28.6 20.0 17.4 19.3
−20.1 −19.7 −16.8 −21.1 −58.9 −109.9 −17.1 −1.6 −7.8 −8.3
Growth
n/a n/a n/a −13.6 −58.0 −108.9 −17.1 −10.4 −13.7 −14.2
0.0 0.0 0.0 0.0 0.3 −0.1 0.0 2.1 0.4 0.0
−22.5 −10.2 −27.1 −13.6 −58.3 −108.8 −17.1 −15.8 −13.6 −14.3
Growth
Per share
n/a n/a n/a n/a −3.48 −74.01 −5.11 −2.86 −2.16 −1.16
n/a n/a n/a n/a −3.48 −74.01 −5.11 n/a n/a n/a
Growth
n/a n/a n/a n/a 16.7 1.5 3.3 5.5 6.3 12.3
n/a n/a n/a n/a 16.7 1.5 3.3 n/a n/a n/a
Growth −91.2% +127.2%

† The diluted share count jumps at 2022 and 2023, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 2.6% a year over five years.
  • Operating margin is up 75.3 points on five years ago, at -14.4%.
  • A net loss in 10 of 10 years on file.